The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic
Markus Hoffmann, Nadine Krüger, Sebastian Schulz, Anne Cossmann, Cheila Rocha, Amy Kempf, Inga Nehlmeier, Luise Graichen, Anna-Sophie Moldenhauer, Martin Sebastian Winkler, Martin Lier, Alexandra Dopfer‐Jablonka, Hans‐Martin Jäck, Georg M. N. Behrens, Stefan Pöhlmann
Topics & Concepts
BiologyNeutralizationCoronavirus disease 2019 (COVID-19)PandemicVirology2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)AntibodyGeneticsVirusInfectious disease (medical specialty)OutbreakDiseasePathologyMedicineSARS-CoV-2 and COVID-19 ResearchCAR-T cell therapy researchMonoclonal and Polyclonal Antibodies Research